iSTAR was established in 2010 as a spinout of Healionics USA with support from Belgium's Region Wallone government to develop its first device: STARflo™ Glaucoma Implant.
Glaucoma is the second leading cause of blindness afflicting approximately 70 million people worldwide.
Language: English French
